Related Experiment Video
Updated: Oct 5, 2025

Method for Measuring the Activity of Deubiquitinating Enzymes in Cell Lines and Tissue Samples
Published on: May 10, 2015
The deubiquitinating enzyme USP20 regulates the stability of the MCL1 protein
Jinan Feng1, Pengyang Liu2, Xiaonan Li3
1Department of Central Laboratory, Luoyang Central Hospital Affiliated to Zhengzhou University, Xigong District, Luoyang, Henan, China; The School of Basic Medical Sciences, Fujian Medical University, Minhou, Fuzhou, China.
Abstract:
Chemoresistance is a major obstacle faced by oesophageal cancer patients and is synonymous with a poor prognosis. MCL1 is a pivotal member of the anti-apoptotic Bcl-2 protein family, which has been found to play an important role in cell survival, proliferation, differentiation and chemoresistance. Thus, it might be an ideal target for treating oesophageal cancer patients. Although it is known that MCL1 is degraded via the ubiquitin-proteasome system, the deubiquitylating enzyme (DUB) responsible for stabilizing MCL1 remains elusive to date. Herein, we demonstrate that Ubiquitin-Specific Protease 20 (USP20) is a novel regulator of the apoptotic signaling pathway. Moreover, USP20 could regulate the deubiquitination of MCL1 to, in turn, regulate its stability. Increased expression of USP20 was correlated with increased levels of MCL1 protein in human patient samples. In addition, depletion of USP20 could increase the polyubiquitination of MCL1, thereby increasing the conversion rate of MCL1 and the sensitivity of cells to chemotherapy. Overall, our findings indicate that the USP20-MCL1 axis might play a key role in the apoptotic signaling pathway.
Insights
Ubiquitin-Specific Protease 20 (USP20) stabilizes MCL1, a protein promoting cancer cell survival. Inhibiting USP20 enhances chemotherapy effectiveness in esophageal cancer by targeting this key axis.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- Chemoresistance presents a significant challenge in esophageal cancer treatment, often leading to poor patient outcomes.
- MCL1, an anti-apoptotic protein, is crucial for cell survival and chemoresistance, making it a potential therapeutic target.
- The deubiquitylating enzyme (DUB) responsible for MCL1 stabilization remained unidentified, hindering targeted therapeutic strategies.
Purpose of the Study:
- To identify the deubiquitylating enzyme (DUB) regulating MCL1 stability.
- To investigate the role of Ubiquitin-Specific Protease 20 (USP20) in the apoptotic signaling pathway and its connection to MCL1.
- To explore the therapeutic potential of targeting the USP20-MCL1 axis in esophageal cancer.
Main Methods:
- Investigated the interaction between USP20 and MCL1.
- Assessed the effect of USP20 depletion on MCL1 ubiquitination and stability.
- Analyzed USP20 and MCL1 expression levels in human patient samples.
- Evaluated the impact of USP20 modulation on chemoresistance in esophageal cancer cells.
Main Results:
- Ubiquitin-Specific Protease 20 (USP20) was identified as a novel regulator of the apoptotic signaling pathway.
- USP20 directly deubiquitinates MCL1, thereby controlling its stability.
- Increased USP20 expression correlated with elevated MCL1 protein levels in patient samples.
- Depletion of USP20 led to increased MCL1 polyubiquitination, enhancing cancer cell sensitivity to chemotherapy.
Conclusions:
- The USP20-MCL1 axis plays a critical role in regulating apoptosis and chemoresistance in esophageal cancer.
- USP20 stabilizes MCL1, contributing to cancer cell survival and treatment resistance.
- Targeting the USP20-MCL1 interaction represents a promising therapeutic strategy to overcome chemoresistance in esophageal cancer.
More Related Videos
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Anaphase Promoting Complex
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Export of Misfolded Proteins out of the ER
Abnormal Proliferation

